Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cellectricon Launches Discovery Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cellectricon Launches Discovery Services

Cytoskeletal offerings aim to shorten development times

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellectricon, a provider of advanced cell-based screening technologies, has launched its Discovery Services division. The new services offer phenotypic screening support to pharma/biotech companies and CROs, aimed at accelerating drug discovery and cell-based assay research into cytoskeletal disturbances, especially for chronic pain.
 
Cellectricon’s Discovery Services aim to shorten lead development times and reduce costs with expertise in assay development and screening. Cellectricon’s Discovery Services team provides interactive collaborative support for the entire services process, with frequent reports on assay performance, observations and
progress.
 
Dr. Paul Karila, head of Cellectricon’s Discovery Services, said, “Our Cellaxess Elektra discovery platform is ideal for compound profiling in excitable primary cells and native tissue using transfection and specific electric field stimulation (EFS). With our platform, we can help researchers identify phenotypic effects in highly relevant biological models early enough in a project’s lifecycle to add real value to the decision of whether to pursue or eliminate a compound, which translates to considerable cost savings in the drug development business.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics